Liang Zhao, Ph.D.

US Food and Drug Administration

Poster(s):

• (M1230-05-30) Application of Quantitative Models to Systematically Evaluate Factors Impacting Swallowability of Tablets
  Monday, October 23, 2023

  12:30 PM – 1:30 PM ET

• (M1430-10-65) Comparing a t-Distribution Based Bayesian Approach with the Two One-Sided t-Test (TOST) for Bioequivalence Studies in Real-World Datasets
  Monday, October 23, 2023

  2:30 PM – 3:30 PM ET

• (T1330-04-26) Effect of Omeprazole Administration on the Pharmacokinetics of Oral Extended-Release Nifedipine: Physiologically Based Pharmacokinetic Modeling
  Tuesday, October 24, 2023

  1:30 PM – 2:30 PM ET

• (T1030-10-66) Identifying Critical Parameters for Physiological Based Pharmacokinetic Modeling of Naloxone Hydrochloride Nasal Sprays
  Tuesday, October 24, 2023

  10:30 AM – 11:30 AM ET

• (W0930-10-67) Utilizing PBPK Absorption Modeling to Evaluate Impact of Single-Sex on Bioequivalence Evaluation of Atorvastatin Immediate Release Tablets
  Wednesday, October 25, 2023

  9:30 AM – 10:30 AM ET